Will Pfizer Help or Hurt Rallying Pharma ETFs?

By tlydon@globaltrend.com (Tom Lydon),

Shutterstock photo

Exchange traded funds (ETFs) that invest in pharmaceuticals and healthcare stocks have rallied even though shares of top holding Pfizer ( PFE ), which reports quarterly results Tuesday morning, stumbled last month.

Pfizer shares fell in mid-April on worries over four deaths in a study for its arthritis drug tofacitinib. The stock has recovered and on Monday touched a new 52-week high.

Pfizer accounts for 12% of Health Care Select Sector SPDR Fund (NYSEArca: XLV). The stock is also the second-largest holding in iShares Dow Jones U.S. Pharmaceuticals Index Fund (NYSEArca: IHE) at 9% of the portfolio. The pharma ETF jumped over 8% in April.

iShares Dow Jones U.S. Pharmaceuticals

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing ETFs
Referenced Stocks: PFE

More from ETF Trends


ETF Trends

ETF Trends

Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by BankRate.com